Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of VVN461 ophthalmic solution for non-infectious anterior uveitis
CTR20253764Phase 3Active
- Sponsor
- VivaVision Biotech
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of VVN461 in anterior uveitis (AAU), sponsored by VivaVision Biotech. Started Sep 2025; status: active.
02
Drugs
VVN461
03
Conditions
anterior uveitis (AAU)
Beyond the preview
Go deeper on CTR20253764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253764.